Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Companion Diagnostics For Breakthrough Drugs Also Getting Swift Attention, FDA Says

Sep 16 2013

Related Content

“Breakthrough Therapy” Development Speed May Be Tempered By Manufacturing Hurdles

Nov 26 2012

CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices

Apr 16 2012

FDA’s Final Risk-Benefit Guidance Excludes 510(k)s, Adds De Novo Petitions

Apr 02 2012

CDRH’s Shuren Signals More Guidance, Enhanced Pre-Market Payer Role

Aug 22 2013

A “Breakthrough” Reality Check: Sponsors Seek FDA Flexibility On Manufacturing, Diagnostics

Jul 08 2013

Additional Topics

Regulation Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window